A novel variant in the LIPA gene associated with distinct phenotype
By:
References
- Ameis D, Merkel M, Eckerskorn C, Greten H. Purification, characterization and molecular cloning of human hepatic lysosomal acid lipase. Eur J Biochem. 1994; 219(3): 905-14.
- Bernstein DL, Hülkova H, Bialer MG, Desnick RJ. Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease. J Hepatol. 2013; 58(6): 1230-43.
- Aslanidis C, Ries S, Fehringer P, Büchler C, Klima H, Schmitz G. Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity. Genomics. 1996; 33(1) :85-93.
- Wilson DP, Patni N. Lysosomal Acid Lipase Deficiency. [Updated 2020 Jan 18]. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK395569/
- Scott SA, Liu B, Nazarenko I, Martis S, Kozlitina J, Yang Y et al. Frequency of the cholesteryl ester storage disease common LIPA E8SJM mutation (c.894G>A) in various racial and ethnic groups. Hepatology. 2013; 58(3): 958-65.
- Cappuccio G, Donti TR, Hubert L, Sun Q, Elsea SH. Opening a window on lysosomal acid lipase deficiency: Biochemical, molecular, and epidemiological insights. J Inherit Metab Dis. 2019; 42(3): 509-18.
- Pisciotta L, Tozzi G, Travaglini L, Taurisano R, Lucchi T, Indolfi G et al. Molecular and clinical characterization of a series of patients with childhood-onset lysosomal acid lipase deficiency. Retrospective investigations, follow-up and detection of two novel LIPA pathogenic variants. Atherosclerosis. 2017; 265: 124-32.
- Zimetti F, Favari E, Cagliero P, Adorni MP, Ronda N, Bonardi R et al. Cholesterol trafficking-related serum lipoprotein functions in children with cholesteryl ester storage disease. Atherosclerosis [Internet]. 2015; 242(2): 443-9.
- Pericleous M, Kelly C, Wang T, Livingstone C, Ala A. Wolman’s disease and cholesteryl ester storage disorder: the phenotypic spectrum of lysosomal acid lipase deficiency. Lancet Gastroenterol Hepatol. 2017; 2(9): 670-9.
- Hůlková H, Elleder M. Distinctive histopathological features that support a diagnosis of cholesterol ester storage disease in liver biopsy specimens. Histopathology. 2012; 60(7): 1107-13.
- Thompson RJ, Portmann BC, Roberts EA. Genetic and metabolic liver disease. In: Burt AD, Portmann BC, Ferrell LD, editors. MacSween’s pathology of the liver (6th edition). Edinburgh: Churchil Livingstone Elsevier, 2012: 157-259
- vom Dahl S, Harzer K, Rolfs A, Albrecht B, Niederau C, Vogt C, van Weely S, Aerts J, Müller G, Häussinger D. Hepatosplenomegalic lipidosis: what unless Gaucher? Adult cholesteryl ester storage disease (CESD) with anemia, mesenteric lipodystrophy, increased plasma chitotriosidase activity and a homozygous lysosomal acid lipase -1 exon 8 splice junction mutation. J Hepatol. 1999; 31(4): 741-6.
- Boenzi S, Deodato F, Taurisano R, Goffredo BM, Rizzo C, Dionisi-Vici C. Evaluation of plasma cholestane-3β,5α,6β-triol and 7-ketocholesterol in inherited disorders related to cholesterol metabolism. J Lipid Res. 2016; 57(3): 361-7.
- Su K, Donaldson E, Sharma R. Novel treatment options for lysosomal acid lipase deficiency: critical appraisal of sebelipase alfa. Appl Clin Genet. 2016; 9: 157-67.
- Pastores GM, Hughes DA. Lysosomal Acid Lipase Deficiency: Therapeutic Options. Drug Des Devel Ther. 2020; 14: 591-601.
- Carter A, Brackley SM, Gao J, Mann JP. The global prevalence and genetic spectrum of lysosomal acid lipase deficiency: A rare condition that mimics NAFLD. J Hepatol. 2019; 70(1): 142-50.
- Del Angel G, Hutchinson AT, Jain NK, Forbes CD, Reynders J. Large-scale functional LIPA variant characterization to improve birth prevalence estimates of lysosomal acid lipase deficiency. Hum Mutat. 2019; 40(11): 2007-20.
- Zhang B, Porto AF. Cholesteryl ester storage disease: protean presentations of lysosomal acid lipase deficiency. J Pediatr Gastroenterol Nutr. 2013; 56(6): 682-5.
- Ruiz-Andrés C, Sellés E, Arias A, Gort L; Spanish LAL Deficiency Working Group. Lysosomal Acid Lipase Deficiency in 23 Spanish Patients: High Frequency of the Novel c.966+2T>G Mutation in Wolman Disease. JIMD Rep. 2017; 37: 7-12.
- Hoffman EP, Barr ML, Giovanni MA, Murray MF. Lysosomal Acid Lipase Deficiency. 2015 Jul 30 [Updated 2016 Sep 1]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK305870/
- Pullinger CR, Stock EO, Movsesyan I, Malloy MJ, Frost PH, Tripuraneni R et al. Identification and metabolic profiling of patients with lysosomal acid lipase deficiency. J Clin Lipidol. 2015; 9(5): 716-26.e1.
- Aerts JM, Hollak CE, van Breemen M, Maas M, Groener JE, Boot RG. Identification and use of biomarkers in Gaucher disease and other lysosomal storage diseases. Acta Paediatr Suppl. 2005; 94(447): 43-6; discussion 37-8.
- Zlatkovic M, Stankovic I, Prokic D, Plamenac P. Patohistoloska dijagnostika bolesti nagomilavanja estra holesterola [Histopathologic diagnosis of cholesterol ester storage disease]. Srp Arh Celok Lek. 2001; 129(7-8): 207-10
- Fasano T, Pisciotta L, Bocchi L, Guardamagna O, Assandro P, Rabacchi C et al. Lysosomal lipase deficiency: molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease. Mol Genet Metab. 2012; 105(3): 450-6.
- Arterburn JN, Lee WM, Wood RP, Shaw BW, Markin RS. Orthotopic liver transplantation for cholesteryl ester storage disease. J Clin Gastroenterol. 1991; 13(4): 482-5.
- Andrade J, Waters PJ, Singh RS, Levin A, Toh BC, Vallance HD et al. Screening for Fabry disease in patients with chronic kidney disease: limitations of plasma alpha-galactosidase assay as a screening test. Clin J Am Soc Nephrol. 2008; 3(1): 139-45.
- Verma J, Thomas DC, Kasper DC, Sharma S, Puri RD, Bijarnia-Mahay S et al. Inherited Metabolic Disorders: Efficacy of Enzyme Assays on Dried Blood Spots for the Diagnosis of Lysosomal Storage Disorders. JIMD Rep. 2017; 31: 15-27.
- Masi S, Chennamaneni N, Turecek F, Scott CR, Gelb MH. Specific Substrate for the Assay of Lysosomal Acid Lipase. Clin Chem. 2018; 64(4): 690-6.
- Lukacs Z, Barr M, Hamilton J. Best practice in the measurement and interpretation of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2. Clin Chim Acta. 2017;471:201-5.
- Monserrat L, Gimeno-Blanes JR, Marín F, Hermida-Prieto M, García-Honrubia A, Pérez I et al. Prevalence of Fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2007; 50(25): 2399-403.
- Vijay S, Brassier A, Ghosh A, Fecarotta S, Abel F, Marulkar S et al. Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies. Orphanet J Rare Dis. 2021; 16(1): 13.
- Mashima R, Okuyama T, Ohira M. Biomarkers for Lysosomal Storage Disorders with an Emphasis on Mass Spectrometry. Int J Mol Sci. 2020; 21(8): 2704.
- Clark WT, Yu GK, Aoyagi-Scharber M, LeBowitz JH. Utilizing ExAC to assess the hidden contribution of variants of unknown significance to Sanfilippo Type B incidence. PLoS One. 2018; 13(7): e0200008.
- Reiner Ž, Guardamagna O, Nair D, Soran H, Hovingh K, Bertolini S et al. Lysosomal acid lipase deficiency-an under-recognized cause of dyslipidemia and liver dysfunction. Atherosclerosis. 2014; 235(1): 21-30.
- Guénard F, Houde A, Bouchard L, Tchernof A, Deshaies Y, Biron S et al. Association of LIPA gene polymorphisms with obesity-related metabolic complications among severely obese patients. Obesity (Silver Spring). 2012; 20(10): 2075-82.
- Stenson PD, Mort M, Ball EV, Evans K, Hayden M, Heywood S et al. The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies. Hum Genet. 2017; 136(6): 665-77.
- Vinje T, Laerdahl JK, Bjune K, Leren TP, Strøm TB. Characterization of the mechanisms by which missense mutations in the lysosomal acid lipase gene disrupt enzymatic activity. Hum Mol Genet. 2019; 28(18): 3043-52.
- Oetjen S, Kuhl D, Hermey G. Revisiting the neuronal localization and trafficking of CLN3 in juvenile neuronal ceroid lipofuscinosis. J Neurochem. 2016; 139(3): 456-70.
- Björses P, Halonen M, Palvimo JJ, Kolmer M, Aaltonen J, Ellonen P et al. Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein. Am J Hum Genet. 2000; 66(2): 378-92.
DOI: https://doi.org/10.2478/bjmg-2022-0010 | Journal eISSN: 2199-5761
Language: English
Page range: 93 - 100
Published on: Mar 1, 2023
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Related subjects:
© 2023 A. Sarajlija, L. Armengol, A. Maver, I. Kitic, D. Prokic, M. Cehic, M.S. Djuricic, B. Peterlin, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.